Bayer's Rivaroxaban Submitted for Approval in Japan Full Text
BayNews International, 04/15/2011
Bayer's rivaroxaban (Xarelto) has been submitted for marketing approval in the prevention of stroke in patients with atrial fibrillation to the Japanese Ministry of Health, Labor and Welfare (MHLW).



